These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical aspects of the treatment of obesity by drugs: a review. Munro JF Int J Obes; 1979; 3(2):171-80. PubMed ID: 393645 [TBL] [Abstract][Full Text] [Related]
4. Diethylpropion and mazindol: An end to the discussion? Lucchetta RC; Riveros BS; Pontarolo R; Radominski RB; Otuki MF; Fernandez-Llimos F; Correr CJ Rev Assoc Med Bras (1992); 2017 Mar; 63(3):203-206. PubMed ID: 28489121 [TBL] [Abstract][Full Text] [Related]
10. Effects of diet, exercise and anorexigenic drugs on serum thyroid hormones. Sonka J; Límanová Z; Zbirková A; Kratochvíl O Endokrinologie; 1980 Dec; 76(3):351-6. PubMed ID: 7472292 [TBL] [Abstract][Full Text] [Related]
11. [Drug-clinics. The hue and cry over central appetite suppressants!]. Scheen AJ Rev Med Liege; 1997 Sep; 52(9):613-5. PubMed ID: 9441348 [No Abstract] [Full Text] [Related]
12. The current status of antiobesity drugs. Galloway SM; Farquhar DL; Munro JF Postgrad Med J; 1984; 60 Suppl 3():19-26. PubMed ID: 6393107 [TBL] [Abstract][Full Text] [Related]
13. Fenfluramine and phentermine. Howlin D Ann Intern Med; 2001 Nov; 135(9):840-1. PubMed ID: 11694113 [No Abstract] [Full Text] [Related]
14. [Therapy of obesity]. Hofmann GG Med Klin; 1976 Jun; 71(23):971-9. PubMed ID: 933996 [No Abstract] [Full Text] [Related]